These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 2957551)
1. Atrial natriuretic peptide in human essential hypertension. Zachariah PK; Burnett JC; Ritter SG; Strong CG Mayo Clin Proc; 1987 Sep; 62(9):782-6. PubMed ID: 2957551 [TBL] [Abstract][Full Text] [Related]
2. Circulating atrial natriuretic polypeptide in essential hypertension. Kohno M; Yasunari K; Matsuura T; Murakawa K; Takeda T Am Heart J; 1987 May; 113(5):1160-3. PubMed ID: 2953220 [TBL] [Abstract][Full Text] [Related]
3. Effect of atrial natriuretic peptide (8-33-Met ANP) in patients with hypertension. Franco-Saenz R; Somani P; Mulrow PJ Am J Hypertens; 1992 May; 5(5 Pt 1):266-75. PubMed ID: 1533767 [TBL] [Abstract][Full Text] [Related]
4. Effects of nitrendipine on blood pressure, renin-angiotensin-system and atrial natriuretic peptide in hypertensive type I diabetic patients. Lehnert H; Schmitz H; Preuss K; Küstner E; Krause U; Beyer J Horm Metab Res; 1993 Jan; 25(1):24-8. PubMed ID: 8428706 [TBL] [Abstract][Full Text] [Related]
5. Plasma levels of atrial natriuretic peptide in patients with borderline and essential hypertension. Nakamura T; Ichikawa S; Sakamaki T; Fujie M; Yagi A; Kurashina T; Murata K Tohoku J Exp Med; 1988 Feb; 154(2):205-13. PubMed ID: 2968004 [TBL] [Abstract][Full Text] [Related]
6. [Atrial natriuretic peptide, left ventricular mass and renin-angiotensin-aldosterone system in essential arterial hypertension of a mild or moderate degree]. Gambini G; Talamonti D; Valori C G Ital Cardiol; 1992 Dec; 22(12):1397-403. PubMed ID: 1294423 [TBL] [Abstract][Full Text] [Related]
8. Plasma atrial natriuretic peptide and its relation to the renin-angiotensin-aldosterone system in patients with chronic renal failure. Selçuk Y; San A; Bakan E; Yiğitoğlu R Nephrol Dial Transplant; 1991; 6(8):557-61. PubMed ID: 1835523 [TBL] [Abstract][Full Text] [Related]
9. Atrial natriuretic peptide and antihypertensive action due to beta-blockade in essential hypertensive patients. Hama J; Nagata S; Takenaka T; Kino H; Kamoi K; Shimada S; Horiuchi M; Katori R Angiology; 1995 Jun; 46(6):511-6. PubMed ID: 7785793 [TBL] [Abstract][Full Text] [Related]
10. Relationship between plasma atrial natriuretic peptide and left atrial and left ventricular involvement in essential hypertension. Wambach G; Bönner G; Stimpel M; Kaufmann W J Hypertens; 1988 Jul; 6(7):573-7. PubMed ID: 2971714 [TBL] [Abstract][Full Text] [Related]
11. Plasma atrial natriuretic peptide in young normotensive subjects with a family history of hypertension and in young hypertensive patients. Santucci A; Ferri C; Cammarella I; Valentino S; Bellini C; Tani S; Musca A; Balsano F Am J Hypertens; 1990 Oct; 3(10):782-5. PubMed ID: 2145867 [TBL] [Abstract][Full Text] [Related]
12. [Atrial natriuretic peptide (ANP) in essential hypertension: a humoral marker for salt sensitivity and hypertensive heart disease at a clinically asymptomatic stage?]. Stimpel M; Kaufmann W; Wambach G Z Kardiol; 1988; 77 Suppl 2():92-8. PubMed ID: 2970180 [TBL] [Abstract][Full Text] [Related]
13. [Effect of a beta 1-receptor blocker on the plasma level of atrial natriuretic peptide in patients with essential hypertension in the exercise test]. Plum J; Hollenbeck M; Heering P; Grabensee B Klin Wochenschr; 1990 May; 68(9):476-84. PubMed ID: 2162449 [TBL] [Abstract][Full Text] [Related]
14. [Increased atrial natriuretic peptide in essential hypertension--relation to right atrial pressure behavior]. Neyses L; Nitsch J; Tüttenberg HP; Korus HC; Lüderitz B Klin Wochenschr; 1989 Aug; 67(15):756-61. PubMed ID: 2528023 [TBL] [Abstract][Full Text] [Related]
15. Raised circulating levels of atrial natriuretic peptides in essential hypertension. Sagnella GA; Markandu ND; Shore AC; MacGregor GA Lancet; 1986 Jan; 1(8474):179-81. PubMed ID: 2868206 [TBL] [Abstract][Full Text] [Related]
16. Effect of beta-adrenergic receptor blockade on atrial natriuretic peptide in essential hypertension. Nakaoka H; Kitahara Y; Amano M; Imataka K; Fujii J; Ishibashi M; Yamaji T Hypertension; 1987 Aug; 10(2):221-5. PubMed ID: 3038746 [TBL] [Abstract][Full Text] [Related]
17. The Bergen Blood Pressure Study: inappropriately low levels of circulating atrial natriuretic peptide in offspring of hypertensive families. Mo R; Myking OL; Lund-Johansen P; Omvik P Blood Press; 1994 Jul; 3(4):223-30. PubMed ID: 7661920 [TBL] [Abstract][Full Text] [Related]
18. Short-term effects of atenolol and nifedipine on atrial natriuretic peptide, plasma renin activity, and plasma aldosterone in patients with essential hypertension. Colantonio D; Casale R; Desiati P; Giandomenico G; Bucci V; Pasqualetti P J Clin Pharmacol; 1991 Mar; 31(3):238-42. PubMed ID: 1826912 [TBL] [Abstract][Full Text] [Related]
19. Liraglutide promotes natriuresis but does not increase circulating levels of atrial natriuretic peptide in hypertensive subjects with type 2 diabetes. Lovshin JA; Barnie A; DeAlmeida A; Logan A; Zinman B; Drucker DJ Diabetes Care; 2015 Jan; 38(1):132-9. PubMed ID: 25414155 [TBL] [Abstract][Full Text] [Related]
20. Plasma and urinary digitalis-like substance levels during atrial natriuretic peptide infusion in essential hypertensive patients. Baldoncini R; Ferri C; Bellini C; Desideri G; De Angelis C; Santucci A Clin Invest Med; 1996 Feb; 19(1):13-9. PubMed ID: 8868311 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]